Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.58%
619.21
+3.56
+0.58%
—615.65615.07619.70614.21——
SX6P
Utilities
SX6P
Utilities
SX6P
-3.70%
530.86
-20.38
-3.70%
—551.24548.70548.70530.09——
SX8P
Technology
SX8P
Technology
SX8P
-1.74%
930.62
-16.46
-1.74%
—947.08946.19946.19917.62——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-1.87%
456.05
-8.70
-1.87%
—464.75463.99464.64453.17——
SXDP
Health Care
SXDP
Health Care
SXDP
-0.35%
1,090.63
-3.82
-0.35%
—1,094.451,093.531,102.341,089.23——
SXEP
Energy
SXEP
Energy
SXEP
-0.14%
535.34
-0.73
-0.14%
—536.07535.49537.10532.16——
SXFP
Financials
SXFP
Financials
SXFP
-0.53%
890.23
-4.73
-0.53%
—894.96895.33896.45886.07——
SXKP
Communications
SXKP
Communications
SXKP
-1.11%
312.78
-3.52
-1.11%
—316.30317.30317.88312.06——
SXNP
Industrials
SXNP
Industrials
SXNP
-2.47%
1,095.60
-27.75
-2.47%
—1,123.351,118.991,118.991,092.58——
SXPP
Materials
SXPP
Materials
SXPP
-5.11%
818.07
-44.02
-5.11%
—862.09841.63841.63810.46——
SGMO:OTCMKTS
Sangamo Therapeutics Inc
$0.14
-0.37%
(-0.00050) 1D
May 15, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGMO...
Open
$0.13
High
$0.14
Low
$0.12
Mkt. cap
54.13M
Avg. vol.
14.58M
Volume
4.17M
52-wk high
$0.77
52-wk low
$0.10
EPS
-$0.44
Beta
1.04
Shares outstanding
414.28M
No. of employees
142
News stories
From sources across the web
Profile
Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California, that develops cell and gene therapies for severe genetic diseases. Wikipedia
About Sangamo Therapeutics Inc
CEOSandy Macrae
Employees142
Founded1995
HeadquartersRichmond, California, United States
SectorBiotechnology
Websitesangamo.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
18.31M
581.00K
14.23M
1.44M
Cost of goods sold
27.08M
28.14M
31.44M
-
Cost of revenue
27.08M
28.14M
31.44M
-
Research and development expenses
-
-
-
26.57M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.08M
7.99M
7.76M
6.82M
Operating expense
9.08M
7.99M
7.76M
33.39M
Total operating expenses
36.16M
36.13M
39.20M
33.39M
Operating income
-17.86M
-35.55M
-24.97M
-31.95M
Other non operating income
-2.49M
207.00K
-21.00K
651.00K
EBT including unusual items
-19.96M
-35.09M
-37.97M
-31.00M
EBT excluding unusual items
-19.96M
-35.09M
-24.74M
-31.00M
Income tax expense
27.00K
-161.00K
-553.00K
-
Effective tax rate
-0.14%
0.46%
1.46%
-
Other operating expenses
-
-
-
-
Net income
-19.99M
-34.93M
-37.42M
-31.00M
Net profit margin
-109.18%
-6,012.05%
-263.00%
-2,149.45%
Earnings per share
-0.08
-0.11
-0.07
-0.08
Interest and investment income
386.00K
355.00K
252.00K
300.00K
Interest expense
-
-
-
-
Net interest expenses
386.00K
355.00K
252.00K
300.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.86M
-34.56M
-24.01M
-31.23M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer